ICT-01(Imcheck Therapeutics) | Interleukin Related interleukin-related.com

Product Name :
ICT-01(Imcheck Therapeutics)

Search keywords :
ICT-01

drugId :
null

Target Vo:
Butyrophilin subfamily 3 member A1

Target Vo Short Name :
CD277

Moa_Name:
Anti-Butyrophilin subfamily 3 member A1

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
ImCheck Therapeutics SAS

Active Company_Name :
ImCheck Therapeutics SAS

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calponin 1 Antibody Description
Evinacumab Purity
HBcAg Antibody (YA910): HBcAg Antibody (YA910) is an unconjugated, mouse-derived, anti-HBcAg (YA910) monoclonal antibody. HBcAg Antibody (YA910) can be used for: IHC-P expriments in human background without labeling.

Author: Interleukin Related

Related Posts